PubMed

A prospective study of change in visual function in patients treated with pegylated interferon alpha for hepatitis C in the UK.

Malik NN, Sheth HG, Ackerman N, Davies N, Mitchell SM.

Br J Ophthalmol. 2008 Feb;92(2):256-8. Epub 2007 Oct 25.PMID: 17962387 [PubMed - indexed for MEDLINE]Related articles

Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.

Scotto G, Fazio V, Fornabaio C, Tartaglia A, Di Tullio R, Saracino A, Angarano G.

Drugs. 2008;68(6):791-801.PMID: 18416586 [PubMed - indexed for MEDLINE]Related articles

Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation.

Chisholm JA, Williams G, Spence E, Parks S, Keating D, Gavin M, Mills PR.

Aliment Pharmacol Ther. 2005 Mar 15;21(6):723-32.PMID: 15771758 [PubMed - indexed for MEDLINE]Related articlesFree article

Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.

Escudero A, Rodríguez F, Serra MA, Del Olmo JA, Montes F, Rodrigo JM.

J Gastroenterol Hepatol. 2008 Jun;23(6):861-6. Epub 2008 Apr 19.PMID: 18422960 [PubMed - indexed for MEDLINE]Related articles

[Results of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in clinical practice: a 5-year experience]

Vergara M, Gallach M, Dalmau B, Gil M, Miquel M, Rudi N, Gavarro A, Cebollero A, Masip M, Real J.

Gastroenterol Hepatol. 2008 May;31(5):274-9. Spanish. PMID: 18448055 [PubMed - indexed for MEDLINE]Related articles

Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.

Kronenberger B, Zeuzem S, Sarrazin C, Mihm U, von Wagner M, Hofmann WP, Piiper A, Herrmann E.

Antivir Ther. 2007;12(5):779-87.PMID: 17713161 [PubMed - indexed for MEDLINE]Related articles

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Senturk H, Tahan V, Canbakan B, Uraz S, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G.

Neth J Med. 2008 May;66(5):191-5.PMID: 18490796 [PubMed - indexed for MEDLINE]Related articlesFree article

[Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics]

Husa P, Slesinger P, Stroblová H, Svobodník A, Husová L.

Klin Mikrobiol Infekc Lek. 2008 Apr;14(2):67-73. Czech. PMID: 18756436 [PubMed - indexed for MEDLINE]Related articles

Anterior ischemic optic neuropathy associated with pegylated interferon therapy for chronic hepatitis C.

Wei YH, Wang IH, Woung LC, Jou JR.

Ocul Immunol Inflamm. 2009 May-Jun;17(3):191-4.PMID: 19585362 [PubMed - indexed for MEDLINE]Related articles

Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study.

Bruno R, Sacchi P, Scagnolari C, Torriani F, Maiocchi L, Patruno S, Bellomi F, Filice G, Antonelli G.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):369-76.PMID: 17635371 [PubMed - indexed for MEDLINE]Related articlesFree article

Pegylated interferon-associated retinopathy in chronic hepatitis C patients.

Ogata H, Suzuki H, Shimizu K, Ishikawa H, Izumi N, Kurosaki M.

Jpn J Ophthalmol. 2006 May-Jun;50(3):293-5. No abstract available. PMID: 16767392 [PubMed - indexed for MEDLINE]Related articles

Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.

Antonini MG, Babudieri S, Maida I, Baiguera C, Zanini B, Fenu L, Dettori G, Manno D, Mura MS, Carosi G, Puoti M.

Infection. 2008 Jun;36(3):250-5. Epub 2008 May 3.PMID: 18458815 [PubMed - indexed for MEDLINE]Related articles

Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.

Iacob S, Gheorghe L, Hrehoret D, Becheanu G, Herlea V, Popescu I.

J Gastrointestin Liver Dis. 2008 Jun;17(2):165-72.PMID: 18568137 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.

Sikole A, Dzekova P, Selja N, Gaseva M, Nikolov IG, Zabzun M, Muharemi S, Asani A, Amitov V, Mena S, Grunevska V, Ivanovski L, Polenakovic M.

Ren Fail. 2007;29(8):961-6.PMID: 18067041 [PubMed - indexed for MEDLINE]Related articles

Evaluation of ocular safety: tirapazamine plus cisplatin in patients with metastatic melanomas.

Prager TC, Kellaway J, Zou Y, Urso RG, McIntyre S, Bedikian AY.

Anticancer Drugs. 1998 Jul;9(6):515-24.PMID: 9877239 [PubMed - indexed for MEDLINE]Related articles

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

Crespo M, Mira JA, Pineda JA, Van den Eynde E, Ríos-Villegas MJ, Collado A, Girón-González JA, López-Cortés LF, González-Serrano M, Rivero A, Merino D, Esteban JI.

J Antimicrob Chemother. 2008 Oct;62(4):793-6. Epub 2008 Jun 21.PMID: 18567911 [PubMed - indexed for MEDLINE]Related articlesFree article

The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.

Akhan SC, Kalender B, Ruzgar M.

Infection. 2008 Aug;36(4):341-4. Epub 2008 Jul 15.PMID: 18629437 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of pegylated interferon/ribavirin combination in 'real world' patients with chronic hepatitis C virus infection.

Borroni G, Andreoletti M, Casiraghi MA, Ceriani R, Guerzoni P, Omazzi B, Terreni N, Salerno F.

Aliment Pharmacol Ther. 2008 May;27(9):790-7. Epub 2008 Feb 21.PMID: 18298638 [PubMed - indexed for MEDLINE]Related articles

Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin.

Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF.

J Infect Dis. 2008 Sep 15;198(6):808-12.PMID: 18657036 [PubMed - indexed for MEDLINE]Related articles

[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]

Roudot-Thoraval F, Abergel A, Allaert F, Bourlière M, Desmorat H, Fagnani F, Fontanges T, Hanana A, Pol S, Zarski JP, Rousseaux C, Gandossi C, Samelson L, Dole S, Dantin S, Eberlé F, Saint-Marc-Girardin MF; Groupe d'Etude Pour Hépavir.

Gastroenterol Clin Biol. 2001 Dec;25(12):1061-6. French. Erratum in: Gastroenterol Clin Biol 2002 Jan;26(1):110. Abelsour, L [corrected to Samelson, L]. PMID: 11910986 [PubMed - indexed for MEDLINE]Related articlesFree article